
Corporate Action16 Oct 2026, 03:13 pm
Shelter Pharma Converts 465,000 Warrants to Equity Shares
AI Summary
Shelter Pharma Ltd announced that its Board of Directors, in a meeting held on October 16, 2026, approved the conversion of 465,000 warrants into 465,000 equity shares. These warrants were initially allotted on a preferential basis. The conversion was made for cash, with the receipt of the remaining exercise price of Rs. 31.6875 per warrant, totaling Rs. 14,734,687.50. This conversion increases the company's paid-up equity share capital from Rs. 168,367,920 to Rs. 173,017,920. The newly allotted shares will rank pari-passu with existing equity shares.
Key Highlights
- Board approved conversion of 465,000 warrants into equity shares.
- Conversion involved receipt of Rs. 14,734,687.50 in cash.
- Paid-up equity share capital increased to Rs. 173,017,920.
- New shares will rank pari-passu with existing equity.
- Application for listing of new shares to be made.
Price Impact
More from SHELTER